Global Wholehealth Partners Corp (GWHP) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
1130 CALLE CORDILLERA SAN CLEMENTE, CA 92673 |
| State of Incorp. | NV |
| Fiscal Year End | June 30 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
| 6/30/2022 Q4 | 12/31/2021 Q2 | 9/30/2021 Q1 | 6/30/2021 Q4 | 3/31/2021 Q3 | 12/31/2020 Q2 | 9/30/2020 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 61,693 | 303,986 | 74,702 | 829 | 6,825 | 132,614 | |||
| Cash and cash equivalent | 61,693 | 303,986 | 74,702 | 829 | 6,825 | 132,614 | |||
| Receivables | 651 | 651 | |||||||
| Inventory, net of allowances, customer advances and progress billings | 93,681 | 29,681 | 29,681 | 155,058 | 209,598 | 214,603 | |||
| Inventory | 93,681 | 29,681 | 29,681 | 155,058 | 209,598 | 214,603 | |||
| Other undisclosed current assets | 156,380 | 309,861 | 299,732 | 551,998 | 26,418 | 2,551 | |||
| Total current assets: | 311,754 | 643,528 | 404,115 | 708,536 | 243,492 | 349,768 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 498,672 | ||||||||
| Property, plant and equipment | 1,856 | 2,147 | 2,438 | 2,729 | 3,020 | 3,311 | |||
| Other undisclosed noncurrent assets | 37,621 | 37,621 | 5,000 | ||||||
| Total noncurrent assets: | 538,149 | 39,768 | 7,438 | 2,729 | 3,020 | 3,311 | |||
| TOTAL ASSETS: | 849,903 | 683,296 | 411,553 | 711,265 | 246,512 | 353,079 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 366,616 | 150,405 | 148,946 | 17,650 | 24,388 | 8,356 | |||
| Interest and dividends payable | ✕ | 6,425 | |||||||
| Accrued liabilities | 4,716 | 2,785 | |||||||
| Other undisclosed accounts payable and accrued liabilities | 355,475 | 150,405 | 146,161 | 17,650 | 24,388 | 8,356 | |||
| Debt | 886,400 | 199,219 | 43,320 | 77,061 | 135,396 | 149,070 | |||
| Due to related parties | 597,577 | 135,603 | 228,598 | 631 | 2,062 | 1,845 | |||
| Other undisclosed current liabilities | 86,009 | 87,785 | 177,177 | 23,387 | 36,875 | ||||
| Total current liabilities: | 1,936,602 | 485,227 | 508,649 | 272,519 | 185,233 | 196,146 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 414,462 | ||||||||
| Operating lease, liability | 414,462 | ||||||||
| Other undisclosed noncurrent liabilities | (414,462) | ||||||||
| Total noncurrent liabilities: | 414,462 | ||||||||
| Total liabilities: | 2,351,064 | 485,227 | 508,649 | 272,519 | 185,233 | 196,146 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (1,501,161) | 198,069 | (97,096) | 438,746 | 61,279 | 156,933 | |||
| Common stock | 87,984 | 83,152 | 78,714 | 72,992 | 59,966 | 59,966 | |||
| Additional paid in capital | 16,309,138 | 15,298,620 | 13,529,861 | 13,508,797 | 4,752,739 | 4,752,739 | |||
| Accumulated deficit | (17,833,783) | (15,215,953) | (13,782,732) | (13,143,043) | (5,181,426) | (4,995,772) | |||
| Other undisclosed equity, attributable to parent | (64,500) | 32,250 | 77,061 | 430,000 | 340,000 | ||||
| Total equity: | (1,501,161) | 198,069 | (97,096) | 438,746 | 61,279 | 156,933 | |||
| TOTAL LIABILITIES AND EQUITY: | 849,903 | 683,296 | 411,553 | 711,265 | 246,512 | 353,079 | |||
Income Statement (P&L) (USD)Annual | Quarterly
| 6/30/2022 Q4 | 12/31/2021 Q2 | 9/30/2021 Q1 | 6/30/2021 Q4 | 3/31/2021 Q3 | 12/31/2020 Q2 | 9/30/2020 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 375 | 276 | 2,460 | 22,075 | 15,385 | |||
| Cost of revenue | (118,824) | (54,540) | (17,588) | (10,544) | ||||
| Gross profit: | 375 | (118,548) | (52,080) | 4,487 | 4,841 | |||
| Operating expenses | (1,879,406) | (1,205,553) | (509,316) | (2,611,380) | (99,847) | (206,048) | ||
| Operating loss: | (1,879,406) | (1,205,178) | (627,864) | (2,663,460) | (95,360) | (201,207) | ||
| Nonoperating income (expense) | (738,424) | (228,043) | 5,434,407 | (5,298,157) | (90,294) | (45,956) | ||
| Interest and debt expense | (195,600) | (86,364) | (5,874) | (760,553) | (30,968) | (4,906) | ||
| Income (loss) from continuing operations: | (2,813,430) | (1,519,585) | 4,800,669 | (8,722,170) | (216,622) | (252,069) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (2,813,430) | (1,519,585) | 4,800,669 | (8,722,170) | (216,622) | (252,069) | |
| Other undisclosed net income | 195,600 | |||||||
| Net income (loss): | (2,617,830) | (1,519,585) | 4,800,669 | (8,722,170) | (216,622) | (252,069) | ||
| Other undisclosed net income (loss) attributable to parent | 86,364 | (5,440,358) | 760,553 | 30,968 | 4,906 | |||
| Net loss available to common stockholders, diluted: | (2,617,830) | (1,433,221) | (639,689) | (7,961,617) | (185,654) | (247,163) | ||
Comprehensive Income (USD)Annual | Quarterly
| 6/30/2022 Q4 | 12/31/2021 Q2 | 9/30/2021 Q1 | 6/30/2021 Q4 | 3/31/2021 Q3 | 12/31/2020 Q2 | 9/30/2020 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (2,617,830) | (1,519,585) | 4,800,669 | (8,722,170) | (216,622) | (252,069) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (2,617,830) | (1,519,585) | 4,800,669 | (8,722,170) | (216,622) | (252,069) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.